Cystic Fibrosis Modulator Therapies

Document first published:
Page updated:
Topic:
Publication type:

This urgent policy statement outlines NHS England’s commissioning position on cystic fibrosis modulator therapies: Ivacaftor; Lumacaftor/Ivacaftor; and Tezacaftor/Ivacaftor.